Publication:
Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

dc.contributor.authorPerez-Vazquez, Maria
dc.contributor.authorOteo-Iglesias, Jesus
dc.contributor.authorSola-Campoy, Pedro J
dc.contributor.authorCarrizo-Manzoni, Hugo
dc.contributor.authorBautista, Veronica
dc.contributor.authorLara, Noelia
dc.contributor.authorAracil, Belen
dc.contributor.authorAlhambra, Almudena
dc.contributor.authorMartinez-Martinez, Luis
dc.contributor.authorCampos, Jose
dc.contributor.funderInstituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades
dc.contributor.funderSpanish Network for Research inInfectious Diseases
dc.contributor.funderEuropean Development Regional Fund ERDF
dc.contributor.groupSpanish Antibiotic Resistance Surveillance Program Collaborating Group
dc.date.accessioned2023-01-25T13:32:26Z
dc.date.available2023-01-25T13:32:26Z
dc.date.issued2019-03-23
dc.description.abstractThere is little information about carbapenemase-producing (CP) Klebsiella oxytoca, an important nosocomial pathogen. We characterized CP K. oxytoca isolates collected from different Spanish hospitals between January 2016 and October 2017. During the study period, 139 nonduplicate CP K. oxytoca isolates were identified; of these, 80 were studied in detail. Carbapenemase and extended-spectrum β-lactamase genes were identified by PCR and sequencing. Genetic relatedness was studied by pulsed-field gel electrophoresis (PFGE). Whole-genome sequencing (WGS), carried out on 12 representative isolates, was used to identify the resistome, to elucidate the phylogeny, and to determine the plasmids harboring carbapenemase genes. Forty-eight (60%) isolates produced VIM-1, 30 (37.5%) produced OXA-48, 3 (3.7%) produced KPC-2, 2 (2.5%) produced KPC-3, and 1 (1.2%) produced NDM-1; 4 isolates coproduced two carbapenemases. By PFGE, 69 patterns were obtained from the 80 CP K. oxytoca isolates, and four well-defined clusters were detected: cluster 1 consisted of 11 OXA-48-producing isolates, and the other three clusters included VIM-1-producing isolates (5, 3, and 3 isolates, respectively). In the 12 sequenced isolates, the average number of acquired resistance genes was significantly higher in VIM-1-producing isolates (10.8) than in OXA-48-producing isolates (2.3). All 12 isolates had chromosomally encoded genes of the blaOXY-2 genotype, and by multilocus sequence typing, most belonged to sequence type 2 (ST2). Carbapenemase genes were carried by IncL, IncHI2, IncFII, IncN, IncC, and IncP6 plasmid types. The emergence of CP K. oxytoca was principally due to the spread of VIM-1- and OXA-48-producing isolates in which VIM-1- and OXA-48 were carried by IncL, IncHI2, IncFII, and IncN plasmids. ST2 and the genotype blaOXY-2 predominated among the 12 sequenced isolates.
dc.description.versionSi
dc.identifier.citationPérez-Vazquez M, Oteo-Iglesias J, Sola-Campoy PJ, Carrizo-Manzoni H, Bautista V, Lara N, et al. Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017. Antimicrob Agents Chemother. 2019 May 24;63(6):e02529-18
dc.identifier.doi10.1128/AAC.02529-18
dc.identifier.essn1098-6596
dc.identifier.pmcPMC6535532
dc.identifier.pmid30936106
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535532/pdf
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc6535532?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/13780
dc.issue.number6
dc.journal.titleAntimicrobial agents and chemotherapy
dc.journal.titleabbreviationAntimicrob Agents Chemother
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number12
dc.provenanceRealizada la curación de contenido 22/08/2024
dc.publisherAmerican Society for Microbiology
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDRD16CIII/0004/0002
dc.relation.projectIDRD16/0016/000
dc.relation.publisherversionhttps://journals.asm.org/doi/10.1128/AAC.02529-18?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.rights.accessRightsopen access
dc.subjectKlebsiella oxytoca
dc.subjectCarbapenemases
dc.subjectcgMLST
dc.subjectPlasmids
dc.subjectWhole-genome sequencing
dc.subject.decsElectroforesis en gel de campo pulsado
dc.subject.decsEspaña
dc.subject.decsFarmacorresistencia bacteriana múltiple
dc.subject.decsProteínas bacterianas
dc.subject.decsPruebas de sensibilidad microbiana
dc.subject.meshBacterial proteins
dc.subject.meshDrug resistance, multiple, bacterial
dc.subject.meshElectrophoresis, gel, pulsed-field
dc.subject.meshHumans
dc.subject.meshKlebsiella oxytoca
dc.subject.meshMicrobial sensitivity tests
dc.subject.meshMultilocus sequence typing
dc.subject.meshPlasmids
dc.subject.meshSpain
dc.subject.meshbeta-lactamases
dc.titleCharacterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number63
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format